MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$8,772,382
EPS
-$2.63
Unit: Dollar
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2026-04-30
Research and development
3,629,785
General and administrative
5,137,056
Total operating expenses
8,766,841
Loss from operations
-8,766,841
Interest income
1,078
Interest expense
6,619
Total other expense, net
-5,541
Net loss
-8,772,382
Net loss available to common shares
-8,772,382
Basic EPS
-2.63
Diluted EPS
-2.63
Basic Average Shares
3,337,143
Diluted Average Shares
3,337,143
Page 1
Unit: Dollar.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss available
to common shares
-$8,772,382
Net loss
-$8,772,382
Loss from operations
-$8,766,841
Total other expense,
net
-$5,541
Interest income
$1,078
Total operating
expenses
$8,766,841
Interest expense
$6,619
General and
administrative
$5,137,056
Research and development
$3,629,785
Buy us a coffee
Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc. (ALZN)